TAMs have been reported to secrete M2-type macrophage markers, including both CCL17 and CCL22; therefore, our study focused on the CCL17/CCL22–CCR4 axis with regard to interactions between TAMs and prostate cancer cells. Here, CCR4 is linked to prostate carcinoma.